MoffittRadOnc @MoffittRadOnc

Product of your friendly local USF Moffitt Cancer Center Radiation Oncology Residents. Highlighting departmental news, successes, research, events. bit.ly/2OZkoEg Tampa, FL Joined August 2019

Tweets

609
Followers

1K
Following

481
Likes

666

ACRO - American College of Radiation Oncology @ACRORadOnc

a week ago

🚨 Reminder for @ACROresident members: the ACRO Resident Committee is hosting 'Bye-Bye Residency Interview Scaries' next week with @JessicaFrakesMD, @MichaelTMilano, & @DrAJEcheverria to answer all your interview-related questions. Register: luma.com/69e2ksq7

0 5 10 675 1

Download Image

Nainesh Parikh @NaineshParikhMD

2 weeks ago

HOT OFF THE PRESS! Neoadjuvant PAE prior to prostate radiation therapy: A single institution experience on the durability of clinical urinary improvement after radiation - ctro.science/article/S2405-… @MoffittNews @MoffittRadOnc @KOSJ12 @gdgrass @VaseemKhatri @ctRO_journal

7 23 65 6K 10

Niema Razavian, MD @RadOncDoc_Niema

3 months ago

#hncsm tumor board❓- what is benefit of concurrent adjuvant chemo in pts w minor (<2mm) ENE? In this multi-inst RR, adjuvant chemo: 🔘 ❌ ⬆️ LRC, DFS, OS for Minor ENE 🔘 ✅ ⬆️ DFS, OS for Major ENE 🔘 ☢️ #radonc ⬆️ DFS for Minor ENE ja.ma/4kMfcOB

3 5 12 1K 2

James Caudell @JJCaudell

3 months ago

Rising PGY-5s and anyone interested, we have a 5th HN rad onc position @MoffittNews. If interested in joining a busy team, including me, Dr. M Echevarria, @BeekeepRadOnc, and @RadOncDoc_Niema, reach out and can chat about the position.

0 14 35 4K 2

Jonathan Zager, MD @jzager99

3 months ago

Moffitt GME Graduation - 46 graduates - congrats to all of you! Good luck and thank you for the years of incredible patient care, ground breaking research and being an integral part of the team. @MoffittNews

1 6 32 2K 0

Download Image

Stephen Rosenberg, MD @SA_Rosenberg

3 months ago

Congratulations to our Graduating Medical and Physics Residents! (Dr. Bryant, Dr. Cruz-Chamorro and Dr. Koo). We are so proud of you and know you will go onto great things! @JMBryantMD @RCruzChamorro @JessicaFrakesMD @EvanWuthrick @KOSJ12 @MoffittRadOnc @MoffittNews #radonc

1 4 32 2K 1

Download Image

ASTRO @ASTRO_org

3 months ago

A multi-institutional phase II trial revealed SBRT and atezolizumab was well tolerated in stage IV cervical cancer with responses in PD-L1 negative tumors. Read it in the #RedJournal. @KAhmedMD @RMWenham @MoffittRadOnc @MoffittGYNONC #radonc tinyurl.com/redahmed

0 5 10 2K 0

Download Image

MoffittRadOnc @MoffittRadOnc

3 months ago

Congratulations to our graduating chief residents for passing their clinical boards!! 🎉💯 @JMBryantMD @RCruzChamorro

0 2 19 2K 0

Download Gif

Moffitt Cancer Center @MoffittNews

3 months ago

From #ASCO25: Kamran Ahmed, MD (@KAhmedMD) highlights results from a phase II trial of SBRT + atezolizumab in metastatic cervical cancer, showing promising responses even in PD-L1 negative tumors. #MoffittASCO25

0 7 21 1K 1

Download Video

James Caudell @JJCaudell

3 months ago

Critical question for C-POST. Without an OS benefit (and no real space between the curves currently), should cemiplimab be reserved for salvage?

David Sher @DavidSherMD

3 months ago

Critical question for C-POST. Without an OS benefit (and no real space between the curves currently), should cemiplimab be reserved for salvage?

1 0 4 2K 0

Download Image

1 2 9 1K 0

Kamran Ahmed @KAhmedMD

3 months ago

Results from our Ph II multi-institutional study now out in @IJROBP redjournal.org/article/S0360-… Overall & objective responses noted in PD-L1 neg metastatic cervical ca with use of SBRT and atezo. Collaboration between @MoffittRadOnc @MoffittGYNONC @OhioStateRadOnc 🤝 @OncoAlert

Moffitt Cancer Center @MoffittNews

3 months ago

0 3 10 4K 0

Download Image

1 13 29 4K 0

Daniel (Donny) Oliver @celloradonc

3 months ago

Congrats, Dr. Upadhyay! @MoffittRadOnc

eContour @eContourRadOnc

3 months ago

Congrats, Dr. Upadhyay! @MoffittRadOnc

0 1 13 2K 0

Download Image

0 1 3 369 0

Editor - Neuro-Oncology Advances @EditorNeuro

4 months ago

Key points of the article: - #Hypofractionated stereotactic #ReIrradiation in combination with nivolumab, ipilimumab, and bevacizumab in patients with recurrent bevacizumab-naïve #HighGradeGlioma is safe. - The median overall survival was 15.6 months bit.ly/3GbAIwO

2 7 20 1K 3

Download Image

Ruben J. Cruz, MD @RCruzChamorro

5 months ago

Grateful for the opportunity to work with this amazing team trying to find more treatment options for patients with recurrent high-grade gliomas!🧠 @MoffittNews @MoffittRadOnc @EditorNeuro @NeuroOnc doi.org/10.1093/noajnl…

0 1 9 548 0

Moffitt Cancer Center @MoffittNews

5 months ago

#FollowFriday Meet Stephen Rosenberg, MD (@SA_Rosenberg), a thoracic oncologist in the radiation department and the Director of Adaptive Radiotherapy. His clinical focus is the treatment of thoracic malignancies, and his research explores the combination of radiation therapy with…

0 4 22 1K 1

Download Image

Stephen Rosenberg, MD @SA_Rosenberg

5 months ago

Great to be speaking at MRinRT conference with great physicians, physicists and colleagues ! Phenomenal work being done! @MoffittNews @MoffittRadOnc #radonc

1 2 16 930 0

Download Image

RT Answers @RTAnswers_org

5 months ago

🎙️ In honor of #HeadandNeckCancerAwarenessMonth, we’re spotlighting a new podcast episode of On Target: Logistics of Radiation Therapy in the Treatment of Head & Neck Cancers. 🎧 Listen now: astro.org/podcasts @RadOncDoc_Niema @EdinaWangMD @ASTRO_org @spohnc_1 @hncalliance

0 4 6 2K 1

Download Video

G. Daniel Grass MD, PhD @gdgrass

5 months ago

Received this letter today. Extremely honored to join this laser-focused group of clinicians/scientists/advocates that work tirelessly to eradicate #bladdercancer. Much to learn & much to do for our patients. Thank you @IBCG_BladderCA for the opportunity.